Sort
17,828 grants matching “crispr”
C/EBPβ in bone marrow stromal cell-mediated drug resistance of multiple myeloma
$237,781Gangqing Hu · West Virginia University · P20 · FY2023 · GM
Genome-Wide CRISPR Activation: A Novel Strategy for Identifying Anti-Aging Targets
$237,763Javier Apfeld · Northeastern University · R21 · FY2024 · AG
Characterization of a New Anti-HIV Immune Protein
$237,750Jay A Levy · University Of California, San Francisco · R21 · FY2017 · AI
Functional long noncoding RNAs in human glioma
$237,750Daniel A Lim · University Of California, San Francisco · R21 · FY2017 · NS
CRISPR-mediated inactivation of ALCAM in myeloid cells
$237,750Rafal Kaminski · Temple Univ Of The Commonwealth · R21 · FY2018 · MH
Core B (Animal Component)
$237,750Jianming Xu · Baylor College Of Medicine · P01 · FY2020 · DK
Core B (Animal Component)
$237,750Jianming Xu · Baylor College Of Medicine · P01 · FY2018 · DK
Antiviral immunity in the Zika virus mosquito vector
$237,750Raul Andino · University Of California, San Francisco · R21 · FY2017 · AI
Core B (Animal Component)
$237,750Jianming Xu · Baylor College Of Medicine · P01 · FY2021 · DK
Core B (Animal Component)
$237,750Jianming Xu · Baylor College Of Medicine · P01 · FY2019 · DK
FANCC mutation correction using homology-independent targeted integration for gene therapy of Fanconi Anemia group C
$237,750Ngoc Tung Tran · Indiana University Indianapolis · R21 · FY2024 · HL
Core B (Animal Component)
$237,750Jianming Xu · Baylor College Of Medicine · P01 · FY2022 · DK
Engineering developmentally-relevant Wnt signaling events to improve iPSC-derived blood-brain barrier models
$237,750Ethan Lippmann · Vanderbilt University · R21 · FY2024 · NS
Core 2: Stanford Breast Metastasis Center Organoid Core
$237,505Calvin J Kuo · Stanford University · U54 · FY2022 · CA
Genetic and Molecular Analysis of a Novel Insulin Regulatory Protein
$237,500Matthew Simon Gill · Scripps Florida · R21 · FY2018 · AG
A novel role of hypusination in controlling regulatory T cell function
$237,500Ye Zheng · Salk Institute For Biological Studies · R21 · FY2022 · AI
Optimization of novel inhibitors of mycolic acid synthesis as TB drug candidates.
$237,288Kyle H Rohde · University Of Central Florida · R21 · FY2024 · AI
Glysocaminoglycan Modifications as Regulators of Alzheimer's Disease-Related Pathologies
$237,285Scott B Selleck · Pennsylvania State University, The · R21 · FY2021 · AG
Matrix Metalloproteinase-19 as a Mediator of Airway Fibrosis in Obese Allergic Asthma
$237,230Jennifer L. Ingram · Duke University · R21 · FY2020 · AI
CAREER: Multilevel Understanding of Biomaterial-Guided CRISPR Delivery
$237,158Tomas Gonzalez-Fernandez · Lehigh University · · FY2025 · MPS
Functional characterization of the telomere repeat containing RNA, TERRA, in telomere maintenance
$237,158Rachel L. Flynn · Boston University Medical Campus · R01 · FY2018 · CA
Project 3: Repurposing Ceritinib for Ovarian Cancer Therapy
$237,156Larry M Karnitz · Mayo Clinic Rochester · P50 · FY2021 · CA
High-throughput discovery of novel transcriptional programs regulating T cell exhaustion
$237,119Weiguo Cui · Northwestern University At Chicago · R21 · FY2024 · AI
Administrative Supplement for R01GM143774 grant
$237,000Rytis Prekeris · University Of Colorado Denver · R01 · FY2024 · GM
Development of an AAV-CRISPR system for inner ear gene therapy
$237,000Jung-Bum Shin · University Of Virginia · R21 · FY2014 · DC